Study of CGB3002 in healthy volunteers
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests a new drug, CGB3002, to see how safe it is and how the body processes it. Healthy volunteers are needed to help determine the right dose and check for side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 54 years old
- Be healthy overall, with no major medical conditions (like heart, lung, or liver disease)
- Have a body mass index (BMI) between 18 and 32, and weigh at least 110 lbs (50 kg) for men or 88 lbs (40 kg) for women
- Not be pregnant or planning pregnancy, and agree to use reliable birth control during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage trial tests a new medicine called GSM-779690T in healthy volunteers to see how safe it is and how the body handles it. Participating could help determine if the medicine is worth testing in people with certain conditions later.
This trial tests a new investigational drug, BMS-986446, given as a single dose to healthy volunteers and multiple doses to people with early Alzheimer's disease. It aims to understand how the drug moves in the body, its safety, and whether it triggers an immune response, which could help guide future treatment for Alzheimer's.
This trial tests a new medicine in healthy people to see how safe it is and how the body handles it. It may help pave the way for future treatments.
This trial tests a new investigational drug called CM383, which is a type of antibody (a protein that helps the immune system) possibly targeting brain plaque linked to Alzheimer's disease. It is an early-stage study in healthy volunteers to check safety and how the drug behaves in the body.
This study tests a new drug (BnH-015B) for people with moderate Alzheimer's disease. It also includes a small group of healthy young men for comparison. The goal is to see if the drug is safe and how it works in the body.
This trial tests a new antibody drug called CM583 in healthy people to see if it is safe and how the body handles it. It may help treat conditions related to certain proteins involved in pain and inflammation.
Hear when a new Alzheimer s Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.